JournalQ1· SCImago 2025
Arthritis and Rheumatology
ISSN 2326-5191
- Q1Quartile
- 4.00SJR
- 373h-index
- 9papers summarised
About this journal
Arthritis and Rheumatology is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 4.00 and an h-index of 373. Most of its papers in the Pofolia pool fall under Rheumatology. Pofolia holds AI summaries of 9 paper(s) from this journal; the most cited is “2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis” (2792 citations).
The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?
Papers we summarise from this journal
- 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis2015 · 2792 citations
- 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus2019 · 2554 citations
- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee2020 · 1959 citations
- Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome2014 · 1440 citations
- Prevalence Trends of Site‐Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 20192022 · 1161 citations
- Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–20162019 · 1100 citations
- Single‐cell RNA sequencing of peripheral blood defines two immunological subtypes of Sjögren's disease distinguished by anti‐SSA antibodies and aberrant B cell populations2026 · 1 citations
- Rheumatology Informatics System for Effectiveness (RISE) Registry Participation Associated with Significant Gains in Quality Measure Performance: An Interrupted Time Series Analysis2026 · 0 citations
- Comparative Safety of Common Immunosuppressant Therapies in Systemic Lupus Erythematosus: A Target Trial Emulation Study2026 · 0 citations
Journals in the same field
| Journal | Quartile | SJR | Summaries |
|---|---|---|---|
| New England Journal of Medicine | Q1 | 18.00 | 9 |
| Signal Transduction and Targeted Therapy | Q1 | 17.00 | 1 |
| Science | Q1 | 10.00 | 1 |
| Annals of the Rheumatic Diseases | Q1 | 7.00 | 1 |
| The Lancet Rheumatology | Q1 | 6.00 | 1 |
| JAMA | Q1 | 5.00 | 2 |
| Bone Research | Q1 | 4.00 | 2 |
| eClinicalMedicine | Q1 | 4.00 | 1 |
| Allergy: European Journal of Allergy and Clinical Immunology | Q1 | 3.00 | 3 |
| Proceedings of the National Academy of Sciences of the United States of America | Q1 | 3.00 | 2 |
See every journal in the field →
Follow these journals on Pofolia
Pick your fields and new papers from their journals land in your feed every day with AI summaries. Free.
Start free